Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
2008/11/04 by U.S. Preventive Services Task Force* · 37 citations
Medicine · #Colorectal Cancer Screening and Detection #Global Cancer Incidence and Screening #Colorectal Cancer Surgical Treatments
paper · pdf · doi:10.7326/0003-4819-149-9-200811040-00243
Abstract
DESCRIPTION: Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for colorectal cancer. METHODS: To update its recommendation, the USPSTF commissioned 2 studies: 1) a targeted systematic evidence review on 4 selected questions relating to test characteristics and benefits and harms of screening technologies, and 2) a decision analytic modeling analysis using population modeling techniques to compare the expected health outcomes and resource requirements of available screening modalities when used in a programmatic way over time. RECOMMENDATIONS: The USPSTF recommends screening for colorectal cancer using fecal occult blood testing, sigmoidoscopy, or colonoscopy in adults, beginning at age 50 years and continuing until age 75 years. The risks and benefits of these screening methods vary. (A recommendation). The USPSTF recommends against routine screening for colorectal cancer in adults 76 to 85 years of age. There may be considerations that support colorectal cancer screening in an individual patient. (C recommendation). The USPSTF recommends against screening for colorectal cancer in adults older than age 85 years. (D recommendation). The USPSTF concludes that the evidence is insufficient to assess the benefits and harms of computed tomographic colonography and fecal DNA testing as screening modalities for colorectal cancer. (I statement).
Cited by
- ACG Clinical Guidelines: Colorectal Cancer Screening 2021
- Adherence to Colorectal Cancer Screening
- Design of the Polish Colonoscopy Screening Program: a randomized health services study
- Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society
- Screening Mammography for Free: Impact of Eliminating Cost Sharing on Cancer Screening Rates
- Colorectal cancer screening: a global overview of existing programmes
- Quality indicators for colonoscopy
- Patient-Reported Barriers to Colorectal Cancer Screening
- Preventive care recommendations to promote health equity
- Health literacy and cancer screening: A systematic review
- Patient-Physician Language Concordance and Use of Preventive Care Services among Limited English Profcient Latinos and Asians
- Knowledge, Attitudes, and Perceptions Around Colorectal Cancer Screening and Risk Among 20–49 Year Olds
- Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. [europepmc]
- Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. [europepmc]
- The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. [europepmc]
- Trends in colorectal cancer test use among vulnerable populations in the United States. [europepmc]
- Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. [europepmc]
- Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. [europepmc]
- Aspirin in the chemoprevention of colorectal neoplasia: an overview. [europepmc]
- Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. [europepmc]
- Contribution of screening and survival differences to racial disparities in colorectal cancer rates. [europepmc]
- Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. [europepmc]
- European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. [europepmc]
- Complications following colonoscopy with anesthesia assistance: a population-based analysis. [europepmc]
- Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. [europepmc]
- Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. [europepmc]
- Long-term colorectal-cancer incidence and mortality after lower endoscopy. [europepmc]
- Health literacy and cancer screening: a systematic review. [europepmc]
- Nutrients, foods, and colorectal cancer prevention. [europepmc]
- Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. [europepmc]
- Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. [europepmc]
- Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. [europepmc]
- Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. [europepmc]
- Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity. [europepmc]
- Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. [europepmc]
- Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. [europepmc]
- Current and future colorectal cancer screening strategies. [europepmc]
Related